RLMD icon

Relmada Therapeutics

90 hedge funds and large institutions have $40.3M invested in Relmada Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 29 closing their positions.

Holders
90
Holders Change
-19
Holders Change %
-17.43%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
26
Reduced
33
Closed
29
Calls
$307K
Puts
$162K
Net Calls
+$145K
Net Calls Change
-$5.58M
Name Market Value Shares Shares
Change
Shares
Change %
HS
101
HighVista Strategies
Massachusetts
-26,299 Closed
GCM
102
Graham Capital Management
Connecticut
-26,258 Closed
PVI
103
Pura Vida Investments
New York
-22,233 Closed
Arrowstreet Capital
104
Arrowstreet Capital
Massachusetts
-21,420 Closed
QT
105
Quantamental Technologies
New York
-15,674 Closed
PMEF
106
Point72 Middle East FZE
United Arab Emirates
-15,517 Closed
CPIG
107
Chicago Partners Investment Group
Illinois
-14,310 Closed
AC
108
AXQ Capital
New Jersey
-12,483 Closed
Walleye Trading
109
Walleye Trading
New York
-12,334 Closed
ETC
110
Exchange Traded Concepts
Oklahoma
-11,981 Closed
TWA
111
TCI Wealth Advisors
Arizona
-1,077 Closed
RTL
112
Red Tortoise LLC
Georgia
-465 Closed
Nisa Investment Advisors
113
Nisa Investment Advisors
Missouri
-400 Closed
Citigroup
114
Citigroup
New York
-185 Closed
Rockefeller Capital Management
115
Rockefeller Capital Management
New York
-27 Closed
IA
116
IFP Advisors
Florida
-2 Closed
BAM
117
Byrne Asset Management
New Jersey
-1 Closed
CS
118
Credit Suisse
Switzerland
-1 Closed
XS
119
XR Securities
Illinois
Wolverine Trading
120
Wolverine Trading
Illinois
FIA
121
FNY Investment Advisers
New York
CFGS
122
Concourse Financial Group Securities
Alabama
CM
123
Caption Management
Oklahoma
CL
124
CSS LLC
Illinois
FRA
125
Front Row Advisors
California
$0 6 +6 New